eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course (Bucharest) - October 2026, Hotel Capital Plaza Bucharest, from 29 October 2026, 08:00 (CET) to 30 October 2026, 12:00 (CET)

Human medicines European public assessment report (EPAR): Ebixa, memantine, Date of authorisation: 15/05/2002, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): Trazimera, trastuzumab, Date of authorisation: 26/07/2018, Revision: 17, Status: Authorised

Meeting Summary - PCWP/HCPWP joint meeting

Human medicines European public assessment report (EPAR): Wyost, denosumab, Date of authorisation: 17/05/2024, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Mepsevii, vestronidase alfa, Date of authorisation: 23/08/2018, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Tolura, telmisartan, Date of authorisation: 04/06/2010, Revision: 15, Status: Authorised

EMA risk management information day

Clinical Trial Information System (CTIS) - Sponsor handbook

Working arrangement for the collaboration and exchange of information on therapeutic products and medicinal products between DG SANTE/EMA and the New Zealand Ministry of Health